We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+17.66%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$680M
AUM Growth
+$49.3M
Cap. Flow
+$17.8M
Cap. Flow %
2.61%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
3
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
RCKT icon
Rocket Pharmaceuticals
RCKT
+$48.4M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$22.5M
3
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$4.95M
4
HRTX icon
Heron Therapeutics
HRTX
+$4.13M

Top Sells

Rank Stock Value
1
RXDX
Ignyta, Inc.
RXDX
+$62.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$263M 38.64%
12,412,338
+210,000
+2% +$4.95M
HRTX icon
2
Heron Therapeutics
HRTX
$86.3M
$239M 35.08%
8,648,252
+181,875
+2% +$4.13M
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
$123M 18.11%
4,138,893
+698,474
+20% +$22.5M
RCKT icon
4
Rocket Pharmaceuticals
RCKT
$348M
$55.6M 8.17%
+2,965,485
New +$48.4M
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
– –
-2,328,279
Closed -$62.2M

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Tang Capital Management held 5 positions worth $680M, up 7.8% from $631M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management's Q1 2018 filing shows 1 new, 3 increased and 1 closed positions. Its largest new stake was Rocket Pharmaceuticals: 2,965,485 shares worth $55.6M. The largest sale was Ignyta, Inc., an estimated $62.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tang Capital Management's largest Q1 2018 buy was Rocket Pharmaceuticals: 2,965,485 shares worth $55.6M.
  • Tang Capital Management added most to La Jolla Pharmaceutical Company in Q1 2018, an estimated $22.5M increase.
  • Tang Capital Management fully exited Ignyta, Inc. in Q1 2018, selling an estimated $62.2M.
  • Tang Capital Management's ten largest holdings make up 100% of its $680M portfolio in Q1 2018.
  • Tang Capital Management opened 1 new position and closed 1 in Q1 2018.
  • Tang Capital Management's portfolio value rose 7.8% quarter-over-quarter to $680M.

Based on Tang Capital Management's 13F filing for Q1 2018, filed 15 May 2018.